NICE has endorsed idebenone (Raxone) on the NHS to treat Leber’s hereditary optic neuropathy in individuals aged 12 and over, offering hope to around 250 people.
The immune system is the body’s natural defence against antigens such as bacteria and viruses, but in some cases, it can malfunction. We explore the prevalence of immune system disorders, the associated unmet medical needs, and therapeutic research.
Medical breakthroughs are quickly being accessed through a ground-breaking initiative, providing manufacturers and innovators with all-encompassing collaborative support.
Dr Nazneen Rahman, Founder and CEO of YewMaker and Sustainable Medicines Partnership (SMP) Director describes how integrating clinical, cost, and carbon effectiveness is key to delivering sustainable healthcare with the Triple-C framework.
Dr Joana Torres, Gastroenterologist, Expert in Clinical IBD and UEG* Rising Star Awardee, highlights the most challenging aspects of living with inflammatory bowel disease and the unmet medical needs in IBD management.
Santosh Rao, Channing J. Paller, Ana Maria Lopez, Eugene Ahn, Jodi MacLeod, Ting Bao, and Linda E. Carlson, from the Society for Integrative Oncology, detail how integrative oncology is transforming cancer care.
Dr Nazneen Rahman, Founder and CEO of YewMaker and Sustainable Medicines Partnership (SMP) Director describes why digital medicine information is essential for sustainable medicines.
David Bloomfield, Consultant in Clinical Oncology Sussex Cancer Centre, argues that precision radiotherapy is our most effective cancer treatment and should be available to everyone with cancer, but workforce planning is failing our patients.
Andrew Nunn, Professor of Epidemiology in the Medical Research Council Clinical Trials Unit at UCL, analyses different tuberculosis drug development regimens.
